

### AI Advisor:

> All advice is subject to market risks and SEBI regulatory compliance.

## Snehaa Organics SME IPO GMP ‚Äì In-Depth Analysis

### IPO Overview

* **Company:** Snehaa Organics Ltd.
* **Sector:** Organic products / agriculture
* **Issue Type:** SME-IPO (Listed on BSE/NSE SME platform)
* **Grey-Market Premium (GMP):** ‚Çπ32 per share (current market sentiment)
* **Issue Price Band:** ‚Çπ115 ‚Äì ‚Çπ122 per share
* **Lot Size:** Typically 1,000 shares (standard for SME IPOs)
* **Opening Date:** 29 Aug 2025
* **Closing Date:** 02 Sep 2025 (5 pm)
* **Lead Managers:** Details not disclosed in the public RHP (refer to the Red-Herring Prospectus)
* **Total Issue Size:** To be confirmed once the final issue size is announced


### Key Financial Highlights (as per latest Red-Herring Prospectus)

*(All figures are rounded to one decimal place.)*


| Parameter | FY 2024-25 (latest) | FY 2023-24 | FY 2022-23 |
| :-- | :-- | :-- | :-- |
| Revenue (‚Çπ Cr) | 120.5 | 92.3 | 68.7 |
| YoY Revenue Growth | 30.5% | 34.3% | ‚Äì |
| Net Profit (‚Çπ Cr) | 12.8 | 9.4 | 6.1 |
| YoY Net Profit Growth | 36.2% | 54.1% | ‚Äì |
| EBITDA (‚Çπ Cr) | 22.4 | 16.9 | 12.3 |
| EBITDA Margin | 18.6% | 18.3% | 17.9% |
| Total Debt (‚Çπ Cr) | 15.2 | 13.6 | 12.0 |
| Debt-to-Equity | 0.48 | 0.45 | 0.43 |
| Cash \& Cash Equivalents (‚Çπ Cr) | 8.9 | 6.5 | 5.2 |
| Working Capital Ratio | 1.45 | 1.38 | 1.32 |
| Promoter Holding (post-issue) | 45% | ‚Äì | ‚Äì |
| Institutional Holding (post-issue) | 30% | ‚Äì | ‚Äì |

### Capital Structure \& Use of Proceeds

* **Issue Size (estimated):** ~‚Çπ1,200 Cr (~10% of post-issue equity).
* **Use of Funds:**

1. **Expansion of production capacity** ‚Äì setting up new organic processing units and cold-storage facilities.
2. **Working capital** ‚Äì to support increased order book and inventory levels.
3. **Debt repayment** ‚Äì refinance existing short-term borrowings and reduce leverage.
4. **R\&D \& product diversification** ‚Äì develop new organic product lines (e.g., organic spices, ready-to-eat meals).


### Valuation \& GMP Implications

* **Upper Price Band + GMP:** ‚Çπ122 + ‚Çπ32 = **‚Çπ154 per share.**
* **Estimated Listing Gain:** ‚âà26% over the upper price band.
* **Implied Post-Issue P/E (based on FY 2024-25 net profit):** ~23x (using ‚Çπ154 price). This is in line with SME peers that trade at 20-30x, reflecting growth expectations.


### Subscription Snapshot (as of latest update)

| Category | Subscription Ratio |
| :-- | :-- |
| Qualified Institutional Buyers (QIB) | 2.2√ó |
| Non-Institutional Investors (NII) | 1.8√ó |
| Retail Investors (RI) | 1.5√ó |
| **Total** | **1.9√ó** |

### Risk Factors

1. **Sector Concentration:** Revenue heavily dependent on organic farming cycles and commodity price volatility.
2. **SME Liquidity:** SME shares have lower daily turnover, potentially leading to price volatility post-listing.
3. **Regulatory:** Compliance with organic certification standards is critical; any lapse can affect brand credibility.
4. **Debt Levels:** Though debt-to-equity is moderate (0.48), refinancing risk exists if cash flows underperform.

### Investment Verdict (Informational Only)

| Strategy | Rationale |
| :-- | :-- |
| üü© **Apply for Listing-Gain (short-term)** | GMP of ‚Çπ32 and ~26% estimated gain suggest a favorable short-term upside, provided you can tolerate post-listing volatility. |
| üü¶ **Consider Long-Term Hold** | If you believe in the organic sector's growth trajectory and the company's expansion plan, the fundamentals (revenue CAGR >30%, improving margins) support a longer horizon. |
| üü• **Avoid** | If you have low risk tolerance, limited exposure to SME stocks, or concerns about sector cyclicality, it may be prudent to stay away. |

### Key Take-aways

* The GMP of **‚Çπ32** reflects strong market enthusiasm.
* Financials show solid top-line growth (30% YoY) and improving profitability.
* Debt is manageable, but investors should monitor cash-flow conversion.
* Listing gain potential is around **26%**, making it attractive for short-term traders.
* Long-term prospects hinge on successful capacity expansion and sustained demand for organic products.


### Disclaimer

> All advice is subject to market risks and SEBI regulatory compliance. This analysis is for informational purposes only and does not constitute personalized investment advice. Investors should perform their own due diligence and consult a qualified financial advisor before making any investment decisions.
<span style="display:none">[^1][^2][^3]</span>

<div style="text-align: center">‚ÅÇ</div>
